Opinion
Civil Action 3:22-cv-00007-CDL
11-22-2023
ABEOME CORPORATION, INC., Petitioner, v. J. HAMPTON STEVENS, LISA L. TORBETT, AND GEORGE CAMPBELL, Dissenters. Dissenters' Exhibits
ORDER TO SEAL
HONORABLE CLAY D. LAND, DISTRICT JUDGE
Abeome Corporation having moved the Court to seal certain exhibits entered into evidence at trial, the Court finds that good cause is shown to seal the following trial exhibits:
Abeome's Exhibits
1
Contribution, Subscription and Assumption Agreement, July 28, 2021
2
Asset Purchase Agreement, Abeome and Alloy Therapeutics, September 30, 2021
17
Abeome Compilation Financial Statements, 2017 - 2019
18
Abeome Compilation Financial Statements, 2020
19
Abeome Profit & Loss Statement, 2020
20
Abeome Compilation Interim Financial Statements, June 2021
21
Deposit Detail, 2020
25
Letter to Shareholders, June 10, 2021
27
Abeome Corporation Capitalization Table, September 15, 2021
Dissenters' Exhibits
D208
Abeome Shareholder Presentation, April 23, 2018
D211
Abeome Shareholder Presentation, May 1, 2019
D217
Abeome Shareholder Presentation, June 25, 2020
D401
License and Assignment Agreement, Abeome and Molecular Templates
D409
Shimkets Email to Alton with Alloy Letter of Intent, March 14, 2021
D410
Letter of Intent, Abeome and Biophtha
D701
Abeome Deposit Detail, 2015 - 2022
D702
Abeome Capitalization Table, April 7, 2022
These filings contain confidential scientific and financial information that belongs not only to Abeome but also to third parties, as well as proprietary information relating to Abeome's intellectual property.
The Clerk of Court and Court Reporter are directed to seal the above-described exhibits. ADDED BY THE COURT: If the Court materially relies upon evidence contained in these exhibits, the Court may reconsider whether those portions of the exhibits should remain under seal.
SO ORDERED.